Brain+ showcased at Danish Dementia Days & Altenpflege in Germany Following the market introduction of the first commercial version of its digital dementia care product, CST Assistant, in Denmark in Q4 2022 and in Germany […]

Brain+ closes its second sales contract for CST  Therapist Companion with a dementia care center in Gladsaxe municipality Brain+ announces to have closed a second sales contract for the company’s new digital dementia product, CST […]

Malteser Hilfsdienst and Brain+ begin collaboration to offer people with dementia access to CST in special dementia cafes in Germany  Brain+ and Malteser Hilfsdienst has started a collaboration to help people with dementia in Germany. The Malteser Hilfsdienst is one of Germany’s […]

Germany sets a new digitalization strategy further supporting the adoption of digital therapeutics in Europe’s largest healthcare market  This month the German Ministry of Health’s shared its new healthcare digitalization strategy, “Gemeinsam Digital”, together with a vision for an integrated digital health […]

Cognitive Stimulation Therapy (CST) enhances the effects of Alzheimer’s disease medicine A key finding from the recently released 2nd systematic Cochrane review (Woods et al., 2023) is the confirmation that medication combined with CST results […]

Brain+ expands its first sales contract close to doubling it In December 2023 Brain+ closed its first sales contract with Herning Municipality, and Herning has chosen to expand that contract, nearly doubling the contractual size. […]

Respected dementia experts and Brain+ get EU grant to research how to optimize digital at-home treatments for people with dementia The EU Joint Programme – Neurodegenerative Disease Research has granted 496,000SEK (or 48,405 euros) to […]

New Cochrane review confirms the benefit and relevance of Cognitive Stimulation Therapy (CST) for people with dementia A 2nd systematic Cochrane review, ‘Cognitive stimulation to improve cognitive functioning in people with dementia’ (Woods et al., 2023), […]

Brain+ showcases its digital dementia products At the Danish-Japanese Welfare and Health Tech Business Conference Brain+ is part of a group of Danish welfare and health tech companies that have been invited to present their […]

Successful conclusion of EU project Alzheimer’s Detect & Prevent  with early validation of two Brain+ DTx technologies and extra funding  The information communicated in this announcement is “inside information” for the purposes of article 7 of […]

Brain+ completes Swedish research version of its dementia product with the Research Institutes of Sweden and extends the collaboration A strong Swedish partner research network Brain+ has over the last three years entered multiple Alzheimer’s […]

Results from a clinical study provide promising feasibility indications for Brain+’ CCT technology for cognitive training A study conducted by Nottingham University as part of the Brain+ led European Horizon2020 project called Alzheimer’s Detect & […]

Brain+ closes 2022 with the first municipal sale of its new dementia product and begins the monetization journey Another milestone has been met by Brain+ as it closes the year with the first sale of […]

3-year innovation project with the Danish Life Science Cluster is completed with the Brain+ CST-Therapist Companion product as the final output A 3-year collaboration project between VIA University College, MedTech Innovation Consortium (MTIC), and Brain+ […]

Brain+ announces Investor Webinar  following strong Q4 with product launch and succesful capital raise Brain+ invites you to an investor webinar after a strong quarter with commercial introduction of its first dementia product, a successful […]

Brain+ begins commercial pilot with volunteers from the DaneAge Association Brain+, a pioneer in the development of digital therapeutics for Alzheimer’s disease, is excited to announce the launch of a pilot project with DaneAge (Ældre Sagen) […]

Brain+ completes the implementation of an ISO 13485 Quality Management System for Medical Devices Brain+ has successfully completed the implementation of an ISO 13485-compliant Quality Management System (QMS). Such a system helps to set standards […]

A new WHO report points to Cognitive Stimulation Therapy (CST) and digital solutions As means to help solve the global dementia burden The World Health Organization (WHO) recently published a large report, A blueprint For Dementia […]

Brain+ adds new clinical and development competences To accelerate and support market access of its digital dementia product portfolio Rising star clinical dementia researcher to join the company in a new position as Clinical Director […]

Brain+ further advances its first digital dementia product, Cognitive Stimulation Therapy (CST) – Therapist Companion Commercial launch in Denmark will be November 1, 2022 Adaptation of a UK product version for the United Kingdom starts […]